FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2162415512> ?p ?o ?g. }

• W2162415512 endingPage "1183" @default.
• W2162415512 startingPage "1172" @default.
• W2162415512 abstract "SummaryBackground: Doxorubicin (DOX) is a widely used anticancer drug for solid tumors and hematologic malignancy, but its active use is hampered by serious adverse effects, including thrombocytopenia. Although bone marrow toxicity of DOX has been suggested to be the sole mechanism underlying the reduced platelet counts, the direct effects of DOX on platelets have never been examined. Objective: Here, we investigated the DOX‐induced platelet cytotoxicity and its underlying mechanism in an effort to elucidate the contribution of platelet cytotoxicity to DOX‐induced thrombocytopenia. Results: In freshly isolated human platelets, DOX induced platelet cytotoxicity in a time‐dependent and concentration‐dependent manner. Reactive oxygen species (ROS) generation, decreased glutathione levels and subsequent protein thiol depletion were shown to underlie the DOX‐induced platelet cytotoxicity. Conspicuously, DOX‐treated platelets displayed apoptotic features such as caspase‐3 activation, reduced mitochondrial transmembrane potential, and phosphatidylserine exposure. Decreased glutathiolation of procaspase‐3 was shown to be a link between protein thiol depletion and caspase‐3 activation. It is of note that DOX‐mediated platelet cytotoxicity was significantly enhanced by shear stress, a common complicating factor in cancer patients. These in vitro results were further confirmed by an in vivo animal model, where administration of DOX induced a platelet count decrease, ROS generation, caspase‐3 activation, protein thiol depletion, and damaged platelet integrity. Conclusion: We demonstrated that DOX can directly induce platelet cytotoxicity through ROS generation, decreased glutathione levels, and protein thiol depletion. We believe that this study provides important evidence for the role of DOX‐induced platelet cytotoxicity in the development of thrombocytopenia in DOX‐treated patients. Background: Doxorubicin (DOX) is a widely used anticancer drug for solid tumors and hematologic malignancy, but its active use is hampered by serious adverse effects, including thrombocytopenia. Although bone marrow toxicity of DOX has been suggested to be the sole mechanism underlying the reduced platelet counts, the direct effects of DOX on platelets have never been examined. Objective: Here, we investigated the DOX‐induced platelet cytotoxicity and its underlying mechanism in an effort to elucidate the contribution of platelet cytotoxicity to DOX‐induced thrombocytopenia. Results: In freshly isolated human platelets, DOX induced platelet cytotoxicity in a time‐dependent and concentration‐dependent manner. Reactive oxygen species (ROS) generation, decreased glutathione levels and subsequent protein thiol depletion were shown to underlie the DOX‐induced platelet cytotoxicity. Conspicuously, DOX‐treated platelets displayed apoptotic features such as caspase‐3 activation, reduced mitochondrial transmembrane potential, and phosphatidylserine exposure. Decreased glutathiolation of procaspase‐3 was shown to be a link between protein thiol depletion and caspase‐3 activation. It is of note that DOX‐mediated platelet cytotoxicity was significantly enhanced by shear stress, a common complicating factor in cancer patients. These in vitro results were further confirmed by an in vivo animal model, where administration of DOX induced a platelet count decrease, ROS generation, caspase‐3 activation, protein thiol depletion, and damaged platelet integrity. Conclusion: We demonstrated that DOX can directly induce platelet cytotoxicity through ROS generation, decreased glutathione levels, and protein thiol depletion. We believe that this study provides important evidence for the role of DOX‐induced platelet cytotoxicity in the development of thrombocytopenia in DOX‐treated patients." @default.
• W2162415512 created "2016-06-24" @default.
• W2162415512 creator A5000088087 @default.
• W2162415512 creator A5017433810 @default.
• W2162415512 creator A5029584856 @default.
• W2162415512 creator A5035970733 @default.
• W2162415512 creator A5056846121 @default.
• W2162415512 creator A5058603990 @default.
• W2162415512 creator A5068679061 @default.
• W2162415512 creator A5069182480 @default.
• W2162415512 creator A5087783301 @default.
• W2162415512 date "2009-07-01" @default.
• W2162415512 modified "2023-09-26" @default.
• W2162415512 title "Doxorubicin‐induced platelet cytotoxicity: a new contributory factor for doxorubicin‐mediated thrombocytopenia" @default.
• W2162415512 cites W1585113202 @default.
• W2162415512 cites W1823056587 @default.
• W2162415512 cites W1850586 @default.
• W2162415512 cites W1968351069 @default.
• W2162415512 cites W1990946341 @default.
• W2162415512 cites W1993085671 @default.
• W2162415512 cites W1994568849 @default.
• W2162415512 cites W1997275271 @default.
• W2162415512 cites W1999468683 @default.
• W2162415512 cites W2000387947 @default.
• W2162415512 cites W2000755827 @default.
• W2162415512 cites W2006274704 @default.
• W2162415512 cites W2010183849 @default.
• W2162415512 cites W2022523356 @default.
• W2162415512 cites W2022872482 @default.
• W2162415512 cites W2035430096 @default.
• W2162415512 cites W2035579766 @default.
• W2162415512 cites W2035701793 @default.
• W2162415512 cites W2036711907 @default.
• W2162415512 cites W2059750107 @default.
• W2162415512 cites W2060697601 @default.
• W2162415512 cites W2067961178 @default.
• W2162415512 cites W2070145271 @default.
• W2162415512 cites W2070194097 @default.
• W2162415512 cites W2085601435 @default.
• W2162415512 cites W2089491860 @default.
• W2162415512 cites W2090135448 @default.
• W2162415512 cites W2106594705 @default.
• W2162415512 cites W2108028750 @default.
• W2162415512 cites W2110128058 @default.
• W2162415512 cites W2118519973 @default.
• W2162415512 cites W2127760782 @default.
• W2162415512 cites W2142544974 @default.
• W2162415512 cites W2143082454 @default.
• W2162415512 cites W2150562016 @default.
• W2162415512 cites W2166520305 @default.
• W2162415512 cites W2166902551 @default.
• W2162415512 cites W2169304723 @default.
• W2162415512 doi "https://doi.org/10.1111/j.1538-7836.2009.03477.x" @default.
• W2162415512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19426282" @default.
• W2162415512 hasPublicationYear "2009" @default.
• W2162415512 type Work @default.
• W2162415512 sameAs 2162415512 @default.
• W2162415512 citedByCount "58" @default.
• W2162415512 countsByYear W21624155122012 @default.
• W2162415512 countsByYear W21624155122013 @default.
• W2162415512 countsByYear W21624155122014 @default.
• W2162415512 countsByYear W21624155122015 @default.
• W2162415512 countsByYear W21624155122016 @default.
• W2162415512 countsByYear W21624155122017 @default.
• W2162415512 countsByYear W21624155122018 @default.
• W2162415512 countsByYear W21624155122019 @default.
• W2162415512 countsByYear W21624155122020 @default.
• W2162415512 countsByYear W21624155122021 @default.
• W2162415512 countsByYear W21624155122022 @default.
• W2162415512 countsByYear W21624155122023 @default.
• W2162415512 crossrefType "journal-article" @default.
• W2162415512 hasAuthorship W2162415512A5000088087 @default.
• W2162415512 hasAuthorship W2162415512A5017433810 @default.
• W2162415512 hasAuthorship W2162415512A5029584856 @default.
• W2162415512 hasAuthorship W2162415512A5035970733 @default.
• W2162415512 hasAuthorship W2162415512A5056846121 @default.
• W2162415512 hasAuthorship W2162415512A5058603990 @default.
• W2162415512 hasAuthorship W2162415512A5068679061 @default.
• W2162415512 hasAuthorship W2162415512A5069182480 @default.
• W2162415512 hasAuthorship W2162415512A5087783301 @default.
• W2162415512 hasBestOaLocation W21624155121 @default.
• W2162415512 hasConcept C109316439 @default.
• W2162415512 hasConcept C126322002 @default.
• W2162415512 hasConcept C181199279 @default.
• W2162415512 hasConcept C185592680 @default.
• W2162415512 hasConcept C190283241 @default.
• W2162415512 hasConcept C202751555 @default.
• W2162415512 hasConcept C203014093 @default.
• W2162415512 hasConcept C2776151105 @default.
• W2162415512 hasConcept C2776694085 @default.
• W2162415512 hasConcept C2780670749 @default.
• W2162415512 hasConcept C2781303535 @default.
• W2162415512 hasConcept C3018697912 @default.
• W2162415512 hasConcept C31573885 @default.
• W2162415512 hasConcept C48349386 @default.
• W2162415512 hasConcept C502942594 @default.
• W2162415512 hasConcept C538909803 @default.
• W2162415512 hasConcept C55493867 @default.

• next